<DOC>
	<DOCNO>NCT03104855</DOCNO>
	<brief_summary>The goal study define 25 ( OH ) D3 catabolism CF patient use gold standard pharmacokinetics study . Specifically , investigator evaluate metabolic clearance 25 ( OH ) D3 among participant CF match control subject . The goal work provide first comprehensive characterization vitamin D metabolism CF patient promote novel hypothesis subsequent study .</brief_summary>
	<brief_title>Clearance 25-hydroxyvitamin D Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Hydroxycholecalciferols</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Calcifediol</mesh_term>
	<criteria>Age â‰¥ 18 year Serum total 25 ( OH ) D 1050 ng/mL Diagnosis cystic fibrosis accordance CF Foundation Guidelines ; OR , normal CONTROL Primary hyperparathyroidism Gastric bypass Tuberculosis sarcoidosis Current pregnancy ChildPugh Class B C cirrhosis ( i.e . cirrhosis ascites , hepatic encephalopathy , bilirubin &gt; =2 mg/dL , serum albumin &lt; =3.5 g/dL , PT &gt; = 4 second ) History kidney transplantation end stage renal disease treat dialysis Use vitamin D3 vitamin D2 supplement exceed mean daily dose 400 IU , within 3 month ( washout allow ) Use 1,25 ( OH ) 2D3 analogue , calcimimetics , medication know induce CYP24A1 within 4 week ( washout allow ) Serum calcium &gt; 10.1 mg/dL Hemoglobin &lt; 9 g/dL</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>cystic fibrosis</keyword>
	<keyword>vitamin catabolism</keyword>
</DOC>